Licensed Pharmacies
Fully Online Care
Free Expedited Delivery
Dedicated Clinical Team
HSA/FSA Accepted
Same-Day Doctor Visits
Verified 2026-09-06

Kongo True Cost 2026: What You'll Actually Pay

Kongo prices semaglutide at $119/month. Based on published pricing, Ozari's annual plan runs about $240 less per year than Kongo, though Kongo costs less than Ozari's month-to-month pricing. Kongo's genuine strengths include legitscript certification seal, all 50 states (stated), injection supplies included and free shipping, no membership fee.

Advertised price

$119/month

True all-in monthly

$119/month

True 12-month cost

$1,428/year

Cost Breakdown

Base semaglutide medication$119/month
Membership / program fee$0/month
First-month differenceNone disclosed
Commitment requiredNone disclosed
Disclosed notePharmacy not named
Disclosed noteCancellation steps and notice period not published

12-Month Comparison vs. Ozari Health

Kongo

$1,428/year

Ozari Health

$1,188–$2,100/year

annual plan to month-to-month

Based on published pricing, Ozari's annual plan runs about $240 less per year than Kongo, though Kongo costs less than Ozari's month-to-month pricing.

See Ozari's current pricing

Frequently Asked Questions

How much does Kongo really cost per month?

Kongo's published semaglutide price is $119/month.

Does Kongo have hidden fees?

Yes, based on published sources: Pharmacy not named; Cancellation steps and notice period not published.

Is Kongo cheaper than Ozari Health?

Based on published pricing, Ozari Health costs about $240 less per year than Kongo.

GLP-1 True Cost Calculator

See what any provider really costs over 12 months

Kongo: $1,428/year · Ozari: $1,188–$2,100/year

Save $240/year with Ozari

See if you qualify for Ozari

Estimates from published pricing sources — confirm current pricing directly with each provider before deciding.

Competitor pricing verified from public sources as of 2026-09-06 and may change. Confirm current pricing directly with each provider. Compounded medications are not FDA-approved.